Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Advertisement

Header Primary Menu

  • Issues
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Home News Chesterfield pharma company enters $600M federal plea deal

Chesterfield pharma company enters $600M federal plea deal

Indivior Solutions Inc. settlement stems from false safety claims about opioid addiction treatment drug

Published July 24, 2020 by Sydney Lake

Less than one month after former Indivior PLC CEO Shaun Thaxter pleaded guilty in federal court in Abingdon to a misdemeanor criminal charge related to the marketing of the Chesterfield County-based company’s opioid addiction treatment drug Suboxone, the company announced Friday it has entered a $600 million plea deal with the U.S. Justice Department, the Federal Trade Commission and U.S. state attorneys general to resolve the issue.

“We are pleased to achieve this resolution and move forward in a way that provides certainty for our business in respect of this matter and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world,” Indivior CEO Mark Crossley said in a statement.

Thaxter stepped down in June as CEO of Indivior, a spinoff of British firm Reckitt Benckiser Group (RB Group), and was replaced by Crossley, the company’s former chief financial and operations officer and executive director. Last year, RB Group agreed to pay $1.4 billion to the federal government and various states to resolve its potential criminal and civil liability in the Suboxone investigation.

Suboxone contains a combination of buprenorphine, a potent opioid, and naloxone, an opioid overdose reversal drug. It is approved for use by people in recovery from opioid addictions to avoid or reduce withdrawal symptoms while receiving treatment for addiction. Thaxter had asked Indivior employees to devise a plan to get Massachusetts Medicaid agency MassHealth to use Suboxone Film instead of a competitor’s non-opiate treatment, according to a criminal complaint filed by the U.S. Attorney’s Office for the Western District of Virginia. 

“Certain Indivior employees subsequently shared false and misleading safety information with MassHealth officials about Suboxone Film’s risk of accidental pediatric exposure,” according to the Justice Department. “Two months after receiving that false and misleading information, MassHealth announced it would provide access to Suboxone Film for Medicaid patients with children under the age of 6.”

Under the terms of the agreement announced Friday, Indivior Solutions Inc., a wholly owned subsidiary of Indivior PLC, has pleaded guilty to one count of making a false statement regarding health care matters in 2012. Indivior will have seven years to pay the $600 million settlement, under which the Justice Department will move to dismiss the charges the grand jury returned in April 2019.

Indivior will make an initial $100 million payment the week the plea is finalized and approved by a judge, according to the company. Then, the company will pay six annual payments of $50 million every Jan. 15 through 2027. 

Indivior has also agreed to pay $10 million to settle Federal Trade Commission (FTC) charges that it violated antitrust laws. The $10 million from this settlement will be combined with an additional $50 million from the RB Group into a fund to provide payments to people who had purchased Suboxone Film.

“In the midst of the nation’s opioid crisis, a critical opioid-addiction treatment was about to become more affordable,” Gail Levine, a deputy director of the FTC’s Bureau of Competition, said in a statement. “But Indivior prevented that. It kept its drug prices high by unlawfully impeding generic manufacturers from competing effectively.”

Starting Friday, anyone who was prescribed Suboxone in the U.S. between March 1, 2013 and Feb. 28, 2019 can file a claim through the FTC to receive payments.

“The incident to which the agreement relates occurred well in the past and does not reflect the values Indivior has strived to demonstrate and uphold during our long history of partnering with health care providers, policymakers, and communities to fight the opioid crisis,” Crossley said in a statement.

 

Subscribe to Virginia Business.

Get our daily e-newsletter.

Related Stories

Virginia Business logo

Ex Chesterfield pharma CEO pleads guilty in federal opioid treatment investigation

Indivior PLC CEO Shaun Thaxter stepped down Monday

Virginia Business logo

Richmond pharmaceutical company expands into Canada

Kaléo will begin selling its epinephrine auto-injector in Canadian pharmacies this month

Virginia Business logo

Central Va. pharma hub strategic plan released

VCU announces strategy to drive business and job growth in region

Trending

Dollar Tree CEO resigning; former Dollar General CEO to replace him

Rivers Casino Portsmouth opens to big crowds

Va. bill aims to reduce mental health stigma for health care workers

Framatome CEO retiring; CFO to be promoted

Former EAB buildings in Henrico sell for $5.35M

Sponsored Stories

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Advertisement

Advertisement

Trending

Dollar Tree CEO resigning; former Dollar General CEO to replace him

Rivers Casino Portsmouth opens to big crowds

Va. bill aims to reduce mental health stigma for health care workers

Framatome CEO retiring; CFO to be promoted

Former EAB buildings in Henrico sell for $5.35M

Sponsored Stories

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk